Insights

Strategic Partnerships Tenaya Therapeutics has recently formed partnerships with prominent investment firms like Piper Sandler & Co and Leerink Transformation Partners, indicating potential new avenues for collaboration and business development opportunities.

Funding Success The company received significant financing with recent funding rounds totaling $53M, showcasing financial stability and potential for investment or product/service expansion, making it an attractive target for strategic partnerships or acquisitions.

Top Talent Acquisition Tenaya Therapeutics appointed Tomohiro Higa as the Interim Principal Accounting Officer, demonstrating a focus on strengthening internal expertise. Identifying key personnel changes could present opportunities to leverage new connections or explore partnership possibilities.

Market Expansion Recent expansion initiatives, such as Virtu Financial's investment of $150K, suggest industry recognition and market interest in Tenaya Therapeutics' offerings. Leveraging this momentum could lead to business growth and capitalizing on emerging market trends.

Competitive Positioning With revenue in the range of $10M - $50M, Tenaya Therapeutics competes with similar companies like CRISPR Therapeutics and Mammoth Biosciences. Understanding the competitive landscape and differentiation strategies can drive targeted sales approaches to gain market share.

Tenaya Therapeutics Tech Stack

Tenaya Therapeutics uses 8 technology products and services including Akamai, MySQL, React, and more. Explore Tenaya Therapeutics's tech stack below.

  • Akamai
    Content Delivery Network
  • MySQL
    Database
  • React
    Javascript Frameworks
  • jQuery Migrate
    Javascript Libraries
  • DocuSign
    Miscellaneous
  • Bootstrap
    UI Frameworks
  • Animate.css
    UI Frameworks
  • Adobe Fonts
    Web Fonts

Media & News

Tenaya Therapeutics's Email Address Formats

Tenaya Therapeutics uses at least 2 format(s):
Tenaya Therapeutics Email FormatsExamplePercentage
FLast@tenayathera.comJDoe@tenayathera.com
95%
Last@tenayathera.comDoe@tenayathera.com
3%
First@tenayathera.comJohn@tenayathera.com
1%
LF@tenayathera.comDJ@tenayathera.com
1%

Frequently Asked Questions

Where is Tenaya Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Tenaya Therapeutics's main headquarters is located at 171 Oyster Point Blvd South San Francisco, California 94080 US. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is Tenaya Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact Tenaya Therapeutics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Tenaya Therapeutics's stock symbol?

Minus sign iconPlus sign icon
Tenaya Therapeutics is a publicly traded company; the company's stock symbol is TNYA.

What is Tenaya Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Tenaya Therapeutics's official website is tenayatherapeutics.com and has social profiles on LinkedIn.

How much revenue does Tenaya Therapeutics generate?

Minus sign iconPlus sign icon
As of April 2025, Tenaya Therapeutics's annual revenue reached $35M.

What is Tenaya Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Tenaya Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Tenaya Therapeutics have currently?

Minus sign iconPlus sign icon
As of April 2025, Tenaya Therapeutics has approximately 128 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Executive Officer: F. A.Chief Technology Officer: K. K.Chief Medical Officer: W. T.. Explore Tenaya Therapeutics's employee directory with LeadIQ.

What industry does Tenaya Therapeutics belong to?

Minus sign iconPlus sign icon
Tenaya Therapeutics operates in the Biotechnology Research industry.

What technology does Tenaya Therapeutics use?

Minus sign iconPlus sign icon
Tenaya Therapeutics's tech stack includes AkamaiMySQLReactjQuery MigrateDocuSignBootstrapAnimate.cssAdobe Fonts.

What is Tenaya Therapeutics's email format?

Minus sign iconPlus sign icon
Tenaya Therapeutics's email format typically follows the pattern of . Find more Tenaya Therapeutics email formats with LeadIQ.

How much funding has Tenaya Therapeutics raised to date?

Minus sign iconPlus sign icon
As of April 2025, Tenaya Therapeutics has raised $53M in funding. The last funding round occurred on Feb 03, 2025 for $53M.

When was Tenaya Therapeutics founded?

Minus sign iconPlus sign icon
Tenaya Therapeutics was founded in 2016.
Tenaya Therapeutics

Tenaya Therapeutics

Biotechnology ResearchCalifornia, United States51-200 Employees

Tenaya Therapeutics is a clinical stage biotechnology company. The Company was founded in 2016 by leading cardiovascular scientists from the David J. Gladstone Institutes and the University of Texas Southwestern Medical Center.

We are a biotechnology company committed to a bold mission: to discover, design, develop and deliver curative therapies that address the underlying drivers of heart disease. Our vision is to change the treatment paradigm for heart disease, and in doing so improve and extend the lives of millions of individuals and families fighting this debilitating disease. We are advancing a pipeline of disease-modifying therapies developed using our product platforms and core internal capabilities to target defined sub-populations of patients with rare or highly prevalent forms of heart disease.

Section iconCompany Overview

Headquarters
171 Oyster Point Blvd South San Francisco, California 94080 US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
TNYA
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
51-200

Section iconFunding & Financials

  • $53M

    Tenaya Therapeutics has raised a total of $53M of funding over 7 rounds. Their latest funding round was raised on Feb 03, 2025 in the amount of $53M.

  • $10M$50M

    Tenaya Therapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $53M

    Tenaya Therapeutics has raised a total of $53M of funding over 7 rounds. Their latest funding round was raised on Feb 03, 2025 in the amount of $53M.

  • $10M$50M

    Tenaya Therapeutics's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.